20 related articles for article (PubMed ID: 9595475)
1. Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2000 Dec; 131(8):1732-8. PubMed ID: 11139453
[TBL] [Abstract][Full Text] [Related]
2. Effects of the novel selective endothelin ET(A) receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2001 Aug; 133(8):1371-7. PubMed ID: 11498524
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of bosentan in patients with chronic heart failure.
Kiowski W; Sütsch G; Oechslin E; Bertel O
Heart Fail Rev; 2001 Dec; 6(4):325-34. PubMed ID: 11447307
[TBL] [Abstract][Full Text] [Related]
4. The role of endothelin receptor antagonists in the treatment of chronic heart failure.
Kiowski W; Sütsch G
Curr Cardiol Rep; 2001 May; 3(3):232-40. PubMed ID: 11305978
[TBL] [Abstract][Full Text] [Related]
5. Unmasking of endothelin-1-induced natriuresis and renal vasodilation in the dog by enrasentan (SB 217242).
Brooks DP; DePalma PD
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S346-7. PubMed ID: 11078416
[TBL] [Abstract][Full Text] [Related]
6. Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
Conrad KP; Gandley RE; Ogawa T; Nakanishi S; Danielson LA
Am J Physiol; 1999 May; 276(5):F767-76. PubMed ID: 10330059
[TBL] [Abstract][Full Text] [Related]
7. Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.
Brooks DP; dePalma PD; Gellai M; Nambi P; Ohlstein EH; Elliott JD; Gleason JG; Ruffolo RR
J Pharmacol Exp Ther; 1994 Nov; 271(2):769-75. PubMed ID: 7965795
[TBL] [Abstract][Full Text] [Related]
8. Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.
Ruetten H; Thiemermann C; Vane JR
Br J Pharmacol; 1996 May; 118(1):198-204. PubMed ID: 8733596
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.
Douglas SA; Edwards RM; Elliott JD; Ohlstein EH
Br J Pharmacol; 1995 Jan; 114(2):405-13. PubMed ID: 7881741
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptor antagonists.
Elliott JD; Ohlstein EH; Peishoff CE; Ellens HM; Lago MA
Pharm Biotechnol; 1998; 11():113-29. PubMed ID: 9760678
[No Abstract] [Full Text] [Related]
11. SB 234551, a novel endothelin--A receptor antagonist, unmasks endothelin-induced renal vasodilatation in the dog.
Brooks DP; DePalma PD; Pullen M; Elliott JD; Ohlstein EH; Nambi P
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S339-41. PubMed ID: 9595475
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
